April 21, 2021
Biomea Announces Closing of Initial Public Offering
REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused…
Pharmaceuticals, Biotechnology and Life Sciences
REDWOOD CITY, Calif., April 20, 2021 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused…
Eddie L. Varnado joins Lumos Pharma as Vice President, Finance and Corporate ControllerAUSTIN, Texas, April 20, 2021 (GLOBE NEWSWIRE) —…
NASHVILLE, Tenn., April 20, 2021 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused…
Company’s Confidence Continues to Grow on Implementation of Proposed Nicotine Cap and Menthol Ban Company is Fully Prepared to Launch…
Treatment Difference between EDP1815 and Placebo for EASI, IGA*BSA, and SCORAD throughout the study treatment period Data presented at the…
COPENHAGEN, Denmark, April 20, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with…
AGOURA HILLS, Calif., April 20, 2021 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), a leading developer…
Pittsburgh, April 20, 2021 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat degenerative…
Firm publishes summary of evidence showing lack of efficacy and risksWEST CONSHOHOCKEN, Pa., April 20, 2021 (GLOBE NEWSWIRE) — To…
04_20 PR Image Delta 8 THC Tauri-Gum™ Blister Pack Sleeve This Initial Production Run has Been Doubled, Due to Strong…